Koei Chin

Dr. Koei Chin is a researcher focused on understanding the mechanisms of genomic instability in cancer initiation and progression, particularly in breast and pancreatic cancers. His work emphasizes identifying molecular targets for early detection and developing therapeutic strategies. He collaborates extensively with institutions on high-impact studies, leveraging multiplex imaging and multiomics approaches to dissect tumor heterogeneity and microenvironment interactions.

His research integrates advanced imaging techniques (e.g., spatial profiling, cyclic immunostaining) to uncover prognostic biomarkers and therapeutic vulnerabilities. Key themes include immune-stromal interactions in breast cancer, replication stress in pancreatic cancer recurrence, and resistance mechanisms in HER2+ tumors. He actively develops standardized frameworks for reproducible data analysis in tissue imaging.

Dr. Chin’s contributions span experimental models, preclinical drug testing (e.g., Juglone-based therapies), and translational studies linking genomic alterations to clinical outcomes. His interdisciplinary approach bridges basic science and clinical applications, aiming to improve precision oncology.